Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study

被引:11
|
作者
Poynter, Jenny N. [1 ,2 ]
Langholz, Bryan [2 ]
Largent, Joan [3 ]
Mellemkjaer, Lene [4 ]
Bernstein, Leslie [5 ]
Malone, Kathleen E. [6 ]
Lynch, Charles F. [7 ]
Borg, Ake [8 ]
Concannon, Patrick [9 ,10 ]
Teraoka, Sharon N. [9 ,10 ]
Xue, Shanyan [2 ]
Diep, Anh T. [2 ]
Torngren, Therese [8 ]
Begg, Colin B. [11 ]
Capanu, Marinela [11 ]
Haile, Robert W. [2 ]
Bernstein, Jonine L. [11 ]
机构
[1] Univ Minnesota, Div Pediat Epidemiol & Clin Res, Minneapolis, MN 55455 USA
[2] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA
[3] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA
[4] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark
[5] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Div Canc Etiol, Duarte, CA 91010 USA
[6] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA
[7] Univ Iowa, Dept Epidemiol, Iowa City, IA USA
[8] Lund Univ, Dept Oncol, Lund, Sweden
[9] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA
[10] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA
[11] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
关键词
Contralateral breast cancer; BRCA1; BRCA2; Reproductive factors; ESTROGEN-RECEPTOR; AGE; CARRIERS; PHENOTYPE; MENARCHE; COHORT; WOMEN; GENE;
D O I
10.1007/s10552-010-9510-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Reproductive factors, such as early age at menarche, late age at menopause, and nulliparity are known risk factors for breast cancer. Previously, we reported these factors to be associated with risk of developing contralateral breast cancer (CBC). In this study, we evaluated the association between these factors and CBC risk among BRCA1 and BRCA2 (BRCA1/2) mutation carriers and non-carriers. The WECARE Study is a population-based multi-center case-control study of 705 women with CBC (cases) and 1,397 women with unilateral breast cancer (controls). All participants were screened for BRCA1/2 mutations and 181 carriers were identified. Conditional logistic regression models were used to evaluate associations between reproductive factors and CBC for mutation carriers and non-carriers. None of the associations between reproductive factors and CBC risk differed between mutation carriers and non-carriers. The increase in risk with younger age at menarche and decrease in risk in women with more than two full-term pregnancies seen in non-carriers were not significantly different in carriers (adjusted RRs = 1.31, 95% CI 0.65-2.65 and 0.53, 95% CI 0.19-1.51, respectively). No significant associations between the other reproductive factors and CBC risk were observed in mutation carriers or non-carriers. For two reproductive factors previously shown to be associated with CBC risk, we observed similar associations for BRCA1/2 carriers. This suggests that reproductive variables that affect CBC risk may have similar effects in mutation carriers and non-carriers.
引用
收藏
页码:839 / 846
页数:8
相关论文
共 50 条
  • [41] Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers
    Kuchenbaecker, Karoline B.
    McGuffog, Lesley
    Barrowdale, Daniel
    Lee, Andrew
    Soucy, Penny
    Dennis, Joe
    Domchek, Susan M.
    Robson, Mark
    Spurdle, Amanda B.
    Ramus, Susan J.
    Mavaddat, Nasim
    Terry, Mary Beth
    Neuhausen, Susan L.
    Schmutzler, Rita Katharina
    Simard, Jacques
    Pharoah, Paul D. P.
    Offit, Kenneth
    Couch, Fergus J.
    Chenevix-Trench, Georgia
    Easton, Douglas F.
    Antoniou, Antonis C.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (07):
  • [42] Prospective evaluation of body size and breast cancer risk among BRCA1 and BRCA2 mutation carriers
    Kim, Shana J.
    Huzarski, Tomasz
    Gronwald, Jacek
    Singer, Christian F.
    Moller, Pal
    Lynch, Henry T.
    Armel, Susan
    Karlan, Beth Y.
    Foulkes, William D.
    Neuhausen, Susan L.
    Senter, Leigha
    Eisen, Andrea
    Eng, Charis
    Panchal, Seema
    Pal, Tuya
    Olopade, Olufunmilayo
    Zakalik, Dana
    Lubinski, Jan
    Narod, Steven A.
    Kotsopoulos, Joanne
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2018, 47 (03) : 987 - 997
  • [43] Outcomes and risk of subsequent breast events in breast-conserving surgery patients with BRCA1 and BRCA2 mutation
    Ye, Fugui
    Huang, Liang
    Lang, Guantian
    Hu, Xin
    Di, Genhong
    Shao, Zhimin
    Cao, Ayong
    CANCER MEDICINE, 2020, 9 (05): : 1903 - 1910
  • [44] Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2 Germline Mutation?
    Emiroglu, Selman
    Ozkurt, Enver
    Cabioglu, Neslihan
    Igci, Abdullah
    Saip, Pinar
    Yazici, Hulya
    Ozmen, Tolga
    Ozmen, Vahit
    Muslumanoglu, Mahmut
    Tukenmez, Mustafa
    BREAST CANCER-TARGETS AND THERAPY, 2023, 15 : 163 - 173
  • [45] The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study
    Rhiem, Kerstin
    Engel, Christoph
    Graeser, Monika
    Zachariae, Silke
    Kast, Karin
    Kiechle, Marion
    Ditsch, Nina
    Janni, Wolfgang
    Mundhenke, Christoph
    Golatta, Michael
    Varga, Dominic
    Preisler-Adams, Sabine
    Heinrich, Tilman
    Bick, Ulrich
    Gadzicki, Dorothea
    Briest, Susanne
    Meindl, Alfons
    Schmutzler, Rita K.
    BREAST CANCER RESEARCH, 2012, 14 (06):
  • [46] Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis
    Basu, N. N.
    Ingham, S.
    Hodson, J.
    Lalloo, F.
    Bulman, M.
    Howell, A.
    Evans, D. G.
    FAMILIAL CANCER, 2015, 14 (04) : 531 - 538
  • [47] A prior diagnosis of breast cancer is a risk factor for breast cancer in BRCA1 and BRCA2 carriers
    Narod, S. A.
    Tung, N.
    Lubinski, J.
    Huzarski, T.
    Robson, M.
    Lynch, H. T.
    Neuhausen, S. L.
    Ghadirian, P.
    Kim-Sing, C.
    Sun, P.
    Foulkes, W. D.
    CURRENT ONCOLOGY, 2014, 21 (02) : 64 - 68
  • [48] Genetic modifiers of cancer risk for BRCA1 and BRCA2 mutation carriers
    Milne, R. L.
    Antoniou, A. C.
    ANNALS OF ONCOLOGY, 2011, 22 : i11 - i17
  • [49] Predicting the Likelihood of Carrying a BRCA1 or BRCA2 Mutation in Asian Patients With Breast Cancer
    Ang, Boon Hong
    Ho, Weang Kee
    Wijaya, Eldarina
    Kwan, Pui Yoke
    Ng, Pei Sze
    Yoon, Sook Yee
    Hasan, Siti Norhidayu
    Lim, Joanna M. C.
    Hassan, Tiara
    Tai, Mei-Chee
    Allen, Jamie
    Lee, Andrew
    Taib, Nur Aishah Mohd
    Yip, Cheng Har
    Hartman, Mikael
    Lim, Swee Ho
    Tan, Ern Yu
    Tan, Benita K. T.
    Tan, Su-Ming
    Tan, Veronique K. M.
    Ho, Peh Joo
    Khng, Alexis J.
    Dunning, Alison M.
    Li, Jingmei
    Easton, Douglas F.
    Antoniou, Antonis C.
    Teo, Soo Hwang
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (14) : 1542 - +
  • [50] Telomere Length Shows No Association with BRCA1 and BRCA2 Mutation Status
    Killick, Emma
    Tymrakiewicz, Malgorzata
    Cieza-Borrella, Clara
    Smith, Paula
    Thompson, Deborah J.
    Pooley, Karen A.
    Easton, Doug F.
    Bancroft, Elizabeth
    Page, Elizabeth
    Leongamornlert, Daniel
    Kote-Jarai, Zsofia
    Eeles, Rosalind A.
    PLOS ONE, 2014, 9 (01):